AORT — ARTIVION, INC.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 784199 ·
Last close
$22.95
Market Cap
$1.12B
52W High
$48.25
52W Low
$19.16
ADV30
656,462
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 116,337,000 | 75,448,000 | 5,787,000 | 1,417,000 | 883,157,000 | 55,764,000 | 432,690,000 |
| Dec 2025 | 115,992,000 | 73,143,000 | 7,180,000 | 2,426,000 | 884,796,000 | 64,908,000 | 436,564,000 |
| Sep 2025 | 113,388,000 | 74,395,000 | 9,036,000 | 6,502,000 | 857,662,000 | 73,426,000 | 418,968,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$57,987,000
Investing CF
$-48,906,000
Financing CF
$7,808,000
CapEx
$-43,406,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.24
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-50,081,000
Inventory
$97,995,000
Receivables
$105,620,000
ST Investments
—
EBIT TTM
$41,700,000
Pretax Income TTM
$17,414,000
Interest Exp TTM
$24,286,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$471,473,984
EBITDA
$63,715,000
Free Cash Flow
$13,096,750
Enterprise Value
$1,553,457,024
Total Cash
$77,316,000
Total Debt
$407,967,008
Shares Out
48,756,221
Trailing EPS
$-0.06
Book Value
$9.15
ROE
-0.7%
ROA
2.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 441,330,000 | 26,745,000 | 9,768,000 | 884,796,000 | 436,564,000 | 448,232,000 | 39,880,000 |
| Dec 2024 | 388,537,000 | 38,874,000 | -13,359,000 | 789,101,000 | 512,901,000 | 276,200,000 | 22,236,000 |
| Dec 2023 | 354,004,000 | -8,508,000 | -30,690,000 | 792,397,000 | 510,617,000 | 281,780,000 | 18,825,000 |
| Dec 2022 | 313,789,000 | 6,201,000 | -19,192,000 | 762,798,000 | 478,469,000 | 284,329,000 | -5,153,000 |
TTM Snapshot
Revenues TTM
$334,330,000
NetIncome TTM
$-5,399,000
OpCashFlow TTM
$0
Assets (Latest)
$789,101,000
Forward EPS
$0.75
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $20.00 · spot: $22.95 · call volume: 13 · put volume: 7
Expected Move to 2027-01-15:
±$5.05
(22.00%) —
implied range
$17.90 –
$28.00
· ATM straddle on $22.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CDRE | Cadre Holdings, Inc. | $1.12B | $26.06 | — |
| IRMD | IRADIMED CORP | $1.11B | $86.66 | — |
| TNDM | TANDEM DIABETES CARE INC | $1.14B | $16.42 | — |
| STVN | Stevanato Group S.p.A. | $1.07B | $21.41 | — |
| ENOV | Enovis CORP | $1.05B | $18.16 | — |
News headlines (Yahoo Finance, 1h cache)
2 Growth Stocks with All-Star Potential and 1 We Find Risky
2026-09-25 14:40 · Yahoo
Artivion’s (AORT) Growth Story Hides A Widening Bottom-Line Problem
2026-09-16 02:49 · Yahoo
3 Reasons to Avoid AORT and 1 Stock to Buy Instead
2026-09-08 14:07 · Yahoo
Artivion (AORT) Bounces As AMDS Launch Narrative Keeps Fair Value In Focus
2026-08-27 16:18 · Yahoo
Why Artivion (AORT) Stock Is Trading Up Today
2026-08-19 21:42 · Yahoo
5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call
2026-08-15 09:09 · Yahoo
Artivion (AORT) Q2 2026 Earnings Call Transcript
2026-08-14 00:46 · Yahoo
Artivion Q2 Earnings Call Highlights
2026-08-07 22:04 · Yahoo
Artivion Inc (AORT) (Q2 2026) Earnings Call Highlights: PMA Approval and Endospan Acquisition ...
2026-08-07 05:11 · Yahoo
Artivion (AORT) Q2 Earnings Meet Estimates
2026-08-06 21:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.